zambia herald : Latest News and In-depth Analysis
HONG KONG,March 18,2025-- In 2024,Roborock,the global leader in ultra-intelligent home robotics engineered to simplify daily life,ranked once again first in global sales volume and turnover amongst R
Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors
SAN FRANCISCO,March 13,2025--In anticipation of the 2025 Game Developers Conference (GDC),Tencent Games,the world\'s leading platform for game development,publishing and operations,today announced it
New automation solutions and material advancements aim to streamline workflows and expand possibilities for dental labs
Company to Showcase AI Offerings and Expanded Cloud Ecosystem. CUPERTINO,Calif.,March 13,2025-- TVU Networks,a pioneer in live video production and a leader in cloud-based media solutions,is marking i
DALLAS,March 13,2025-- Armor,a leading provider of cybersecurity and compliance solutions,today announced it has joined the Oracle Partner Program. As an Oracle partner,Armor will collaborate with Or
YONGIN,South Korea,March 13,2025-- GC Cell (KRX:144510),under the leadership of CEO Sungyong Won,announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205),a novel CD
MELBOURNE,Australia and INDIANAPOLIS,March 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces that it has developed and validated a breakthrough generato
